A study by Kartal et al. included a large population of 1827 psoriasis patients receiving conventional immunosuppressive (methotrexate and cyclosporine) and systemic biologic therapy (anti‐TNF or anti‐IL drugs).7 This evidence concerns the gene TNF and psoriasis.